During the past decade, Hospital Quirónsalud Málaga conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Quirónsalud Málaga" #1 sponsor was "Abivax S.A." with 2 trials, followed by "Inmunotek S.L." with 2 trials sponsored, "Procare Health Iberia S.L." with 2 trials sponsored, "Boston Scientific Corporation" with 1 trials sponsored and "Eli Lilly and Company" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Quirónsalud Málaga" #1 collaborator was "Adknoma Health Research" with 2 trials as a collaborator, "Althaia Xarxa Assistencial Universitària de Manresa" with 1 trials as a collaborator, "BioClever 2005 S.L." with 1 trials as a collaborator, "Centro Medico Teknon" with 1 trials as a collaborator and "Complejo Hospitalario de Navarra" with 1 trials as a collaborator. Other collaborators include 14 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Quirónsalud Málaga" are "Ulcerative Colitis" (2 trials), "Allergic Conjunctivitis" (1 trials), "Allergic Rhinoconjunctivitis" (1 trials), "Asthma, Allergic" (1 trials) and "Cervix Lesion" (1 trials). Many other conditions were trialed in "Hospital Quirónsalud Málaga" in a lesser frequency.

Most popular intervention types in "Hospital Quirónsalud Málaga" are "Drug" (6 trials), "Device" (3 trials), "Biological" (2 trials), "Procedure" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "10,000 MG01 + 10,000 T517" (1 trials), "30,000 MG01 + 10,000 T517" (1 trials), "ABX464" (1 trials) and "ABX464 100mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Quirónsalud Málaga" are 11 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Quirónsalud Málaga". undefined are not yet recruiting, 5 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Hospital Quirónsalud Málaga, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Quirónsalud Málaga, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".

Hospital Quirónsalud Málaga has several departments that took part in Clinical trials: "Hospital Quiron de Madrid; Servicio de Neurologia" - 13 trials, "Hospital Universitari Dexeus - Grupo Quironsalud; Servicio de Oncologia Medica" - 10 trials, "Hospital Quiron de Madrid; Servicio de Oncologia" - 9 trials, "Hospital Quiron Barcelona; Servicio de Oncologia" - 9 trials, "Hospital Quiron. I.C.U." - 4 trials, "Hospital QuironSalud Barcelona - Next Oncology" - 3 trials, "Hospital Infanta Luisa, Servicio de Reumatologia" - 3 trials, "Departamento de Ginecología Obstetricia y Reproducción. Hospital Universitari Dexeus" - 2 trials, "Hospital Quiron de Madrid; Servicio de Hematologia" - 2 trials, "University Hospital Quiron Madrid, Department of Oncology" - 2 trials